Apolipoprotein D: a potential biomarker for cerebral amyloid angiopathy
H. Bea Kuiperij(Radboud University Nijmegen), Marcel M. Verbeek(Radboud University Nijmegen)
Cited by 26
Related Papers
A Practical Guide to Immunoassay Method Validation
|Frontiers in Neurology|2015|541
CSF biomarker variability in the Alzheimer's Association quality control program
|Alzheimer s & Dementia|2013|386
Tyrosine hydroxylase deficiency: a treatable disorder of brain catecholamine biosynthesis
|Brain|2010|233
Association of Cerebral Amyloid-β Aggregation With Cognitive Functioning in Persons Without Dementia
|JAMA Psychiatry|2017|148
An enzyme immunoassay to quantify neurofilament light chain in cerebrospinal fluid
|Journal of Immunological Methods|2004|82